Articles by William Looney - Pharmaceutical Executive

ADVERTISEMENT

Articles by William Looney

2012 Dealmakers Outlook

Jun 1, 2012

Pharm Exec convened a panel of heavy hitters in business development to crack the bat on best practices in licensing and M&A for the year ahead.

From the Editor:The Connections Game

Jun 1, 2012

As the old Broadway song goes, June is busting out all over—and true to the season this month's issue stretches the seams with content that ranges from the sublime to the ridiculous.

Information Overload

May 1, 2012

Data has become as important as the drug in driving success in healthcare.

Pharma 50 Comment: Seeding Beyond the Base

May 1, 2012

The industry's reputation as a growth industry no one wants to pay for is more secure than ever, writes Pharm Exec Editor William Looney.

Succeeding in Pharma as a Woman or Minority Professional

Apr 24, 2012

Broaden your industry exposure. Think beyond yourself... Timely advice from this year's HBA Woman of the Year, Carolyn Buck Luce.

IP: Time for a Reset?

Apr 4, 2012

IP must adapt to new ways of extracting value from assets the industry never knew it had, writes William Looney.

HBA Woman of the Year 2012

Apr 1, 2012

Throughout her life, HBA Woman of the Year Carolyn Buck-Luce has made progress by recognizing that when one door closes, another one opens.

Emerging Markets: Setting a New Agenda

Apr 1, 2012

India's most prominent scientist, Dr R.A. Mashelkar, President of the Global Research Alliance, on delivering medicines profitably but cheaply to low income countries.

IP: Time for a Reset?

Apr 1, 2012

Patents are the chief incentive for drug development. Industry should educate stakeholders about IP protection as a crucial driver of innovation, before it's too late.

ADVERTISEMENT

Click here